Sun Pharma
Indian Pharma Giants Expand Globally Amid Slowing Domestic Growth
Indian pharmaceutical giants like Sun Pharma and Coforge are expanding globally as domestic growth slows. Discover their strategies for success.
Sun Pharma Q4 Earnings Report: 26% Profit Surge and Dividend Announcement
Sun Pharma reports a 26% profit increase in Q4, reaching ₹2,714 crore, and announces a ₹5 per share dividend, showcasing strong market performance.
Trading Insights: Strategies for Goodluck India, Sun Pharma, and More
Discover trading strategies for stocks like Goodluck India and Sun Pharma. Enhance your investment approach with our expert insights.
Sun Pharma’s $11.75 Billion Acquisition of Organon: A Game Changer
Sun Pharma has made headlines with its $11.75 billion acquisition of Organon, marking a significant step in the biopharma industry.
Sun Pharma Acquires Organon in $11.75 Billion Deal, Shares Surge
Sun Pharma has announced a $11.75 billion acquisition of Organon, boosting its market presence and share value by 5%.
Top Stocks to Monitor on April 27: Sun Pharma, RIL, Axis Bank & More
Key stocks to watch on April 27 include Sun Pharma, RIL, and Axis Bank. Stay updated with market trends and investment strategies.
Sun Pharma Shares Dip Over 3% Following $13 Billion Organon Bid News
Sun Pharma shares have fallen by over 3% amid news of a $13 billion bid for Organon, raising questions about the future of the acquisition.